Study Title: Pharmacodynamic Biomarkers to Support Biosimilar Development: 
Clinical Study 1 (IL-5 Antagonists – Mepolizumab and Reslizumab)  
 Document Title:  Clinical Study Protocol – Study No.  SCR -006 
 
Document Date:  25 June  2020  
 
Study ID: [REMOVED] 
Digitally signed by [CONTACT_468779] -S 
DN: c=US, o=U.S. Government, ou=HHS, ou=FDA, ou=People, cn=David Strauss -S, 0.9.2342.19200300.100.1.1=[PHONE_9806] 
Date: 2020.06.28 21:36:40 -04'00'